Clinical Trial Is Favorable for a Prenatal Gene Test
By Andrew Pollack,
The New York Times
| 08. 08. 2012
A new method of prenatal testing that can detect more genetic problems in a fetus than ever before could be headed toward wider use after encouraging results from a clinical trial, researchers said.
The study, which is expected to be published in a peer-reviewed medical journal soon, found that the new technique, microarray, surpassed standard testing in detecting chromosomal abnormalities that can cause problems like autism or mental retardation.
“The last 8 to 12 months have probably seen the greatest change we’ve had in prenatal screening and diagnostics since the development of amniocentesis,” which became popular in the 1970s, said Dr. Lee Shulman, head of reproductive genetics at Northwestern University’s Feinberg School of Medicine.
The new technique still requires fetal cells to be obtained either by amniocentesis, in which a long needle is stuck into the womb, or by another invasive procedure called chorionic villus sampling, in which tissue is taken from the placenta. But instead of then examining the fetal chromosomes under a microscope, a DNA-sensing chip is used to detect abnormalities too small to be seen...
Related Articles
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
